Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Profound Medical Corp.

    NASDAQ: PROF · Real-Time Price · USD
    5.99
    -0.16 (-2.60%)
    At close: Jun 27, 2025, 3:59 PM
    6.00
    0.17%
    After-hours: Jun 27, 2025, 04:04 PM EDT

    Profound Medical Statistics

    Share Statistics

    Profound Medical has 30.05M shares outstanding. The number of shares has increased by 22.97% in one year.

    Shares Outstanding

    n/a
    		 30.05M

    Shares Change (YoY)

    n/a
    		 22.97%

    Shares Change (QoQ)

    n/a
    		 0.04%

    Owned by Institutions (%)

    n/a
    		 55.89%

    Shares Floating

    n/a
    		 26.58M

    Failed to Deliver (FTD) Shares

    n/a
    		 200

    FTD / Avg. Volume

    n/a
    		 0.25%

    Short Selling Information

    The latest short interest is 535.46K, so 1.78% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 535.46K

    Short % of Shares Out

    n/a
    		 1.78%

    Short % of Float

    n/a
    		 2.15%

    Short Ratio (days to cover)

    n/a
    		 8.88

    Valuation Ratios

    The PE ratio is -7.02 and the forward PE ratio is -3.6. Profound Medical's PEG ratio is 0.41.

    PE Ratio

    n/a
    		 -7.02

    Forward PE

    n/a
    		 -3.6

    PS Ratio

    n/a
    		 17.41

    Forward PS

    n/a
    		 1.3

    PB Ratio

    n/a
    		 3.08

    P/FCF Ratio

    n/a
    		 -7.93

    PEG Ratio

    n/a
    		 0.41
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Profound Medical.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 10.52, with a Debt / Equity ratio of 0.08.

    Current Ratio

    n/a
    		 10.52

    Quick Ratio

    n/a
    		 9.64

    Debt / Equity

    n/a
    		 0.08

    Debt / EBITDA

    n/a
    		 -0.15

    Debt / FCF

    n/a
    		 -0.22

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $75,211.27

    Profits Per Employee

    n/a
    		 $-186,482.05

    Employee Count

    n/a
    		 142

    Asset Turnover

    n/a
    		 0.15

    Inventory Turnover

    n/a
    		 0.63

    Taxes

    Income Tax

    n/a
    		 -2K

    Effective Tax Rate

    n/a
    		 0.01%

    Stock Price Statistics

    The stock price has increased by -30.97% in the last 52 weeks. The beta is 0.25, so Profound Medical's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.25

    52-Week Price Change

    n/a
    		 -30.97%

    50-Day Moving Average

    n/a
    		 5.33

    200-Day Moving Average

    n/a
    		 6.73

    Relative Strength Index (RSI)

    n/a
    		 54.46

    Average Volume (20 Days)

    n/a
    		 78,567

    Income Statement

    In the last 12 months, Profound Medical had revenue of 10.68M and earned -26.48M in profits. Earnings per share was -1.12.

    Revenue

    n/a
    		 10.68M

    Gross Profit

    n/a
    		 7.04M

    Operating Income

    n/a
    		 -33.06M

    Net Income

    n/a
    		 -26.48M

    EBITDA

    n/a
    		 -33.06M

    EBIT

    n/a
    		 -33.06M

    Earnings Per Share (EPS)

    n/a
    		 -1.12
    Full Income Statement

    Balance Sheet

    The company has 54.91M in cash and 5.12M in debt, giving a net cash position of 49.79M.

    Cash & Cash Equivalents

    n/a
    		 54.91M

    Total Debt

    n/a
    		 5.12M

    Net Cash

    n/a
    		 49.79M

    Retained Earnings

    n/a
    		 -245.02M

    Total Assets

    n/a
    		 60.86M

    Working Capital

    n/a
    		 54.62M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -23.45M and capital expenditures 0, giving a free cash flow of -23.45M.

    Operating Cash Flow

    n/a
    		 -23.45M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -23.45M

    FCF Per Share

    n/a
    		 -0.95
    Full Cash Flow Statement

    Margins

    Gross margin is 65.89%, with operating and profit margins of -309.57% and -247.94%.

    Gross Margin

    n/a
    		 65.89%

    Operating Margin

    n/a
    		 -309.57%

    Pretax Margin

    n/a
    		 -247.96%

    Profit Margin

    n/a
    		 -247.94%

    EBITDA Margin

    n/a
    		 -309.57%

    EBIT Margin

    n/a
    		 -309.57%

    FCF Margin

    n/a
    		 -219.6%

    Dividends & Yields

    PROF does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for PROF is $11.5, which is 87.6% higher than the current price. The consensus rating is "Strong Buy".

    Price Target

    n/a
    		 $11.5

    Price Target Difference

    n/a
    		 87.6%

    Analyst Consensus

    n/a
    		 Strong Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Oct 16, 2019. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Oct 16, 2019

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 2.93

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist